Sartorius Stedim Biotech SA (STU:56S1)
€ 193.8 -3.9 (-1.97%) Market Cap: 18.88 Bil Enterprise Value: 22.44 Bil PE Ratio: 57.41 PB Ratio: 6.74 GF Score: 91/100

Q1 2023 Sartorius AG and Sartorius Stedim Biotech SA Earnings Call Transcript

Apr 20, 2023 / 01:30PM GMT
Release Date Price: €254.3 (-9.21%)
Operator

Good day, and welcome to the Sartorius and Sartorius Stedim Biotech Conference Call on the Q1, 2023 Results. Today's conference is being recorded.

At this time, it's my pleasure, and I would like to turn the conference over to Dr. Joachim Kreuzburg, CEO of Sartorius Group. Please go ahead, sir.

Joachim Kreuzburg
Sartorius Aktiengesellschaft - Chairman of Executive Board & CEO

Thank you very much, and also welcome from our side to our today's conference call on the Q1 results for 2023 for Sartorius as well as for Sartorius Stedim Biotech. We will run the call slightly differently from the previous times. I will make the introduction, as always, then Rainer will walk you through the main results for the Sartorius Group as well as for the divisions.

And then Rene Faber, who is leading the Bioprocess Solutions Division at Sartorius since 4 years and now is also the CEO of Sartorius Stedim Biotech will then focus on the Sartorius Stedim Biotech's numbers. Therefore, we will also slightly shift the presentation between BPS and SSB. Usually, we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot